Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
CC transcript
Inv. presentation
Jazz Pharmaceuticals plc (JAZZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance – Strong execution delivered second quarter 2023 total revenues of $957 million –"
05/10/2023 8-K Quarterly results
Docs: "Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance Focus on commercial execution drove 1Q23 total revenues of $892.8 million"
03/01/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance Strong Execution Drove Record Revenues in 2022 of $3.7 billion, an increase of 18% over 2021"
01/09/2023 8-K Investor presentation
Docs: "Presentation slides by Jazz Pharmaceuticals plc on January 9, 2023",
"Presentation slides by Jazz Pharmaceuticals plc on January 9, 2023"
01/04/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
12/21/2022 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
10/19/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
Docs: "Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance"
05/04/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
04/07/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE ™ Molecule"
03/28/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Jazz Pharmaceuticals Announces Agreement to Divest Sunosi ® to Axsome Therapeutics"
03/01/2022 8-K Quarterly results
01/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Jazz Pharmaceuticals Announces Vision 2025 to Deliver Sustainable Growth and Enhanced Value to Drive Transformation to Innovative, Global Biopharmaceutical Leader"
11/09/2021 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS AND RAISES FULL YEAR EARNINGS GUIDANCE"
09/23/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/03/2021 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS"
07/28/2021 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
07/19/2021 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Deloitte & Touche LLP",
"Audited consolidated financial statements of GW as of and for the years ended December 31, 2020 and 2019, and the notes related thereto",
"Unaudited consolidated financial statements of GW as of March 31, 2021 and December 31, 2020 and for the three months ended March 31, 2021 and 2020, and the notes related thereto",
"Unaudited pro forma condensed combined financial statements as of and for the three months ended March 31, 2021 and for the year ended December 31, 2020, and the notes related thereto"
07/01/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Jazz Pharmaceuticals Announces U.S. FDA Approval of Rylaze ™ -rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma"
05/05/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
04/29/2021 8-K Quarterly results
04/23/2021 8-K Quarterly results
04/22/2021 8-K Quarterly results
04/20/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
03/22/2021 8-K Quarterly results
02/23/2021 8-K Quarterly results
02/03/2021 8-K Quarterly results
02/03/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy